FR 2024-29132

Overview

Title

Bacillus Thuringiensis Cry1Da2 Protein; Exemption From the Requirement of a Tolerance

Agencies

ELI5 AI

The government has decided that a special safe ingredient used to protect corn from bugs doesn't need strict rules about how much can be in the corn, because it's not harmful. This means corn farmers can use it more easily.

Summary AI

The Environmental Protection Agency (EPA) has established an exemption from the requirement for a tolerance for the Bacillus thuringiensis Cry1Da2 protein used as a plant protectant in corn (field, sweet, and pop). This means that there is no need to set a maximum permissible level for these residues on corn products. Pioneer Hi-Bred International, Inc. requested this exemption, and the EPA concluded that the protein is safe, posing no significant risk of toxicity or allergenicity from exposure, including dietary intake. As a result, an analytical method for enforcement is not necessary.

Abstract

This regulation establishes an exemption from the requirement of a tolerance for residues of the Bacillus thuringiensis Cry1Da2 protein in or on the food and feed commodities of corn: corn, field; corn, sweet; and corn, pop, when used as a plant-incorporated protectant (PIP). Pioneer Hi-Bred International, Inc., (Pioneer) submitted a petition to EPA under the Federal Food, Drug, and Cosmetic Act (FFDCA), requesting an exemption from the requirement of a tolerance. This regulation eliminates the need to establish a maximum permissible level for residues of Cry1Da2 protein.

Type: Rule
Citation: 89 FR 100746
Document #: 2024-29132
Date:
Volume: 89
Pages: 100746-100749

AnalysisAI

The document is a final rule issued by the Environmental Protection Agency (EPA) regarding a specific protein, Bacillus thuringiensis Cry1Da2, used in corn as a plant-incorporated protectant. The EPA has granted an exemption from the requirement of a tolerance for residues of this protein on corn, meaning there is no need to set a maximum permissible level for these residues on food and feed commodities of corn. This exemption was requested by Pioneer Hi-Bred International, Inc., and the EPA determined that the protein is safe, presenting no significant risk of toxicity or allergenicity based on its comprehensive review.

General Summary

For those not deeply entrenched in regulatory language or scientific jargon, the rule essentially concludes that the Bacillus thuringiensis Cry1Da2 protein is safe for use in corn. This decision means that farmers and food producers using this protein do not need to worry about the legal thresholds of it being present in corn products, a decision expected to streamline regulatory processes and potentially reduce costs associated with regulatory compliance.

Significant Issues and Concerns

There are notable issues within the document that may warrant closer scrutiny. Firstly, the document does not mention any cost analysis or financial impact assessment related to the implementation of this regulation. Often, federal rules would include some economy-focused evaluation to ensure that benefits outweigh costs and that undue burdens are not imposed on various stakeholders. Absence of this discussion leaves readers without a clear understanding of any economic implications.

Furthermore, while Pioneer Hi-Bred International, Inc., is recognized as the petitioner for this exemption, the document does not clarify whether other organizations had access to a similar process for exemptions. This absence might suggest an appearance of favoritism, potentially affecting perceptions of transparency and fairness in regulatory practices.

Scientific and regulatory terminology can be dense and complex, potentially hindering the public's ability to engage meaningfully with the document. The lack of simplified explanations or accessible data summaries further compounds this issue, making it difficult for those without specialized knowledge to fully understand the rationale behind the exemption.

Broader Public Impact

The public's interaction with corn products, whether through consumption or other industries relying on corn, will likely not see any immediate changes due to this rule. The EPA's decision is based on safety evaluations that show no expected harm from the exposure to this protein, thus maintaining public health assurances.

Impact on Stakeholders

Positive Impact:

For agricultural producers and the pesticide industry, this ruling represents a positive development. By eliminating the need for specific tolerance levels, these stakeholders can potentially reduce costs associated with regulatory compliance. Such cost reductions could lead to improved efficiency and potentially lower prices for consumers in the long run.

Negative Impact:

However, the lack of a detailed financial impact analysis or public competitive process for similar exemptions can be seen as a limitation or a missed opportunity for these industries. Some stakeholders might feel disadvantaged or left out of the policy-making process, especially if they perceive an exclusive benefit granted to a single company without disclosure of a broader framework for similar considerations.

In summary, while the EPA's ruling is technically sound and aligned with existing safety standards, its presentation and process may leave questions unanswered for those affected by or interested in agricultural biotechnology regulations. The document navigates a significant regulatory space yet could benefit from an approach that might enhance public transparency and understanding.

Issues

  • • The document does not provide specific details on the cost implications or funding mechanisms related to the implementation of the regulation, which could help evaluate any wasteful spending concerns.

  • • There is no indication of a financial impact analysis or cost-benefit analysis, which would typically be necessary to ensure that the regulation does not impose unnecessary costs or financial burdens.

  • • The regulation mentions Pioneer Hi-Bred International, Inc., as the petitioner for the exemption, but does not clarify if there was a competitive or public process for similar exemptions, potentially presenting an appearance of favoritism.

  • • The text uses complex scientific and legal terminology that may not be easily understood by laypersons or those not familiar with regulatory language, potentially limiting public understanding and engagement.

  • • While the document explains the safety determination for the Cry1Da2 protein, it does not provide detailed layperson-friendly explanations or data summaries that can help a non-expert assess the rationale behind the exemption.

  • • The document references several other documents (e.g., Human Health Risk Assessment) necessary for complete understanding but does not provide direct links or summaries within the main text, which could improve transparency and accessibility.

Statistics

Size

Pages: 4
Words: 3,378
Sentences: 100
Entities: 241

Language

Nouns: 1,165
Verbs: 254
Adjectives: 175
Adverbs: 43
Numbers: 139

Complexity

Average Token Length:
4.96
Average Sentence Length:
33.78
Token Entropy:
5.80
Readability (ARI):
22.52

Reading Time

about 13 minutes